Director/PDMR Shareholding

RNS Number : 1559B

Venture Life Group PLC

14 June 2016

 

Venture Life Group PLC

("Venture Life" or the "Company")

Director/PDMR Shareholding

Bracknell, UK - 14 June 2016: Venture Life Group plc (AIM: VLG), the international consumer healthcare group addressing the self-care needs of the ageing population, announces that it was informed on 13 June 2016 that Ms. Sharon Collins, the Commercial Director of the Company, has undertaken dealings in 27,030 ordinary shares of 0.3p each in the Company ("Ordinary Shares"), transferring 26,430 of her current holding of Ordinary Shares to her ISA, and selling and re-purchasing 600 Ordinary Shares to be held in her non-ISA account.

The dealings were made between 8 June 2016 and 13 June 2016 as set out below:

Date	Dealing type	Number of Ordinary Shares sold	Number of Ordinary Shares purchased	Price (p)
8 June 2016	Sale	26,600	-	57.00
8 June 2016	Purchased to ISA	-	26,000	57.10
9 June 2016	Sale	430	-	57.00
9 June 2016	Purchased to ISA	-	430	57.00
Total sold		27,030	-
Total purchased to ISA		-	26,430
13 June 2016	Purchase	-	600	59.49
Total dealings		27,030	27,030

Following the dealings, Ms. Collins's beneficial interest in the Company remains unchanged at 1,582,417 Ordinary Shares, representing approximately 4.3% of the issued share capital in the Company.

For further information please contact:

Venture Life Group PLC

Jerry Randall, Chief Executive Officer                                                    [phone]

James Hunter, Chief Financial Officer                                                   

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)                             
Freddy Crossley                                                                                                               [phone]

Peter Steel

Duncan Monteith                                                                                                           
Corporate Finance

Tom Salvesen
Corporate Broking                                                                                                          

Square1 Consulting

David Bick

Brian Alexander                                                                                                               [phone]

About Venture Life

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.

The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

Through its manufacturing company, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

 

END

 

 

DSHLLFLLRDISLIR